Munoz featured in Pharma’s Almanac
Feb 22, 2023
CRB’s plasma derived therapies market sector lead, Eddie Munoz, recently participated in a roundtable with Pharma’s Almanac. Industry leaders looked to the future of the international pharmaceutical and biotech markets to provide their unique insights for the article, “In what international markets do you anticipate significant developments in the near future?”
Focusing on his area of expertise, Munoz points to the needs of plasma therapy production, examining demand growth and a fragile supply chain.
While demand continues to grow, the global PDT supply chain has several pinch points:
- Donar reliant
- Heavy donor restrictions in other countries
- Many countries rely on the U.S. for their source plasma
European countries are actively working to strengthen their PDT supply chain through advocacy and legislation. As they do so, the world’s PDT manufacturers will be watching every step of the way.
Read the full article: In what international markets do you anticipate significant developments in the near future?